The INDICAID™ COVID-19 Rapid Antigen Test (FDA EUA) is a lateral flow immunoassay designed for the qualitative detection of SARS-CoV-2 antigens in direct nasal swab samples.
Quick: With INDICAID™, users can expect quick results in just 20 minutes.
Easy: User-friendly testing. No additional equipment or training is required.
Simple Sampling: INDICAID™ comes with intuitive vials to obtain self-collected shallow nasal samples.
Bulk Testing: Our rapid COVID-19 test offers bulk sample collection and testing, great for high volume screening.
For In Vitro Diagnostic Use Only
Professional Use Only
The INDICAID™ COVID-19 Rapid Antigen Test Rapid detects antigens from SARS-CoV-2 virus and can be used for COVID-19 screening during active infection
|Items per box||25x|
|Specimen type||Direct Anterior Nasal swab|
|Intended use||Qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct nasal swab samples from individuals who are suspected of COVID-19 by their healthcare provider within the first five (5) days of symptom onset|
36º-86ºF (2º-30ºC) Do not freeze. Avoid direct sunlight.
Product Sales and Customer Services
Sales Email: firstname.lastname@example.org
Technical Support :
+1 (657) 296-6106 (9am – 6pm Pacific)